Optimus Pharma, a leading Indian pharmaceutical manufacturer and subsidiary of Sekhmet Pharmaventures, announced that it has received regulatory marketing approval for Tapinarof cream, an...
AstraZeneca and Daiichi Sankyo announced that their antibody-drug conjugate Enhertu (trastuzumabderuxtecan) has achieved a statistically significant and clinically meaningful improvement in progression-free survival in the Phase...
argenx SE (Euronext & Nasdaq: ARGX) reported on August 17 that its Phase 3 ALKIVIA trial of subcutaneous efgartigimod (marketed as VYVGART Hytrulo) achieved its primary goal in...
Pfizer Inc. and Valneva SE announced that the European Medicines Agency has formally accepted for review the Marketing Authorization Application for their jointly developed Lyme disease...
In a major regulatory and administrative reform, the Government of Telangana has merged the Food Safety Department and the Drugs Control Department into a...
Caplin Point Laboratories Ltd has signed a Memorandum of Understanding (MoU) committing an investment of ₹925 crore to establish four new state-of-the-art pharmaceutical manufacturing...